Medications

Candidate vaccine against MERS passes first test

In collaboration with colleagues in Rotterdam, an LMU research team led by Professor Gerd Sutter has produced the first candidate vaccine against the MERS virus, a novel and highly pathogenic coronavirus.

Medical research

Prion-like proteins drive several diseases of aging

Two leading neurology researchers have proposed a theory that could unify scientists' thinking about several neurodegenerative diseases and suggest therapeutic strategies to combat them.

Medical research

The flexible tail of the prion protein poisons brain cells

For decades, there has been no answer to the question of why the altered prion protein is poisonous to brain cells. Neuropathologists from the University of Zurich and University Hospital Zurich have now shown that it is ...

Immunology

Boosting immunity—and vaccine research

Vaccination has achieved huge success in controlling many devastating infectious diseases. However, there are still many such diseases, or 'pathogens', against which we cannot generate life-long protective immunity. On the ...

Diseases, Conditions, Syndromes

Saudi announces four new deaths from MERS virus

Four more people have died from the MERS virus in Saudi Arabia, bringing the death toll from the SARS-like virus in the kingdom to 32, the health ministry said Monday.

page 14 from 27